Share Market Update: Sensex Falls Over 350 Points As Markets Retreat From Record Highs
Domestic stock markets retreated from record levels on Tuesday tracking weakness across Asian equities, as concerns about increasing COVID-19 deaths and lockdowns overshadowed optimism about the rollout of coronavirus vaccinations. The S&P BSE Sensex index fell 383.6 points, or 0.83 per cent, to 45,869.86 at the weakest level during the session, and the broader NSE Nifty 50 benchmark dropped to as low as 13,451.30, down 106.85 points, or 0.79 per cent, from its previous close. Weakness across sectors, led by banking, financial services and IT shares, dragged the markets lower. (Also Read: Stocks to Watch Today)
At 10:43 am, the Sensex traded 351.74 points, or 0.76 per cent, lower at 45,901.72, while the Nifty was down 95.85 points, or 0.71 per cent, at 13,462.30. (Track Sensex, Nifty Here)
Tata Motors, HUL, ITC, ICICI Bank and Axis Bank, trading between 1.79 per cent and 2.28 per cent lower, were the worst hit among 37 laggards in the 50-scrip Nifty basket.Â
On the other hand, Eicher Motors, Shree Cement, UltraTech Cement, HCL Tech and Wipro, up 0.76-2.48 per cent each, were the top gainers in the index.Â
Reliance Industries, ICICI Bank, Hindustan Unilever and ITC were the biggest drags on Sensex.Â
Both the indices had scaled all-time highs in 16 of the past 24 sessions, boosted by record inflows from foreign institutional investors and progress on COVID-19 vaccines globally.
Official data released after market hours on Monday showed consumer inflation eased last month but still remained outside the Reserve Bank of India's comfort zone, reinforcing analysts' view that the central bank's Monetary Policy Committee may keep key rates on hold for now. (Also Read:Â RBI Likely To Keep Policy Rates On Hold, Say Analysts)
Asian share markets moved lower, with MSCI's index of Asia-Pacific shares outside Japan down 0.40 per cent at the last count, having hit a string of record highs last week.
The E-Mini S&P 500 futures were up 0.10 per cent, indicating a positive start for US markets on Tuesday.
On Monday, tighter COVID-19 restrictions were imposed on London as the government citing increased infection rates that may be partly linked to a new variant of the coronavirus.
News of the vaccines has powered gains in the last few months, with the Asian benchmark up nearly 16 per cent so far this year, sitting just shy of a record struck last week.
Last week, the United States authorised the emergency use of its first COVID-19 vaccine, developed by Pfizer and BioNTech. The vaccine has already been authorised in a handful of countries including Britain and Canada.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.